99% Savings - Buy Just @1 Rs X
Roczid 1000 Injection is a commercial drug that is prescribed in the form of Injection. It is primarily used for the treatment of Skin Infections, Pneumonia. Roczid 1000 Injection also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Roczid 1000 Injection. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
Apart from the aforementioned side effects, Roczid 1000 Injection can also lead to other problems, which have been listed below. These side effects of Roczid 1000 Injection are usually temporary and subside with the completion of treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, Roczid 1000 Injection's effect is Safe during pregnancy and Safe for lactating mothers. In addition, Roczid 1000 Injection's effects on the liver, heart and kidney are discussed below in the Roczid 1000 Injection related warnings section.
Roczid 1000 Injection can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Roczid 1000 Injection in conditions like Kidney Disease. Other contraindications of Roczid 1000 Injection have been discussed in the sections ahead.
Drug reaction of Roczid 1000 Injection with other medicines has been reported. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Roczid 1000 Injection is considered not safe while driving, and is not addictive.
Roczid 1000 Injection is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Infant (1 month to 2 years) |
|
Neonates (0 to 1 month) |
|
Is the use of Roczid 1000 Injection safe for pregnant women?
Pregnant women can take Roczid safely.
Is the use of Roczid 1000 Injection safe during breastfeeding?
Roczid is safe for breastfeeding women.
What is the effect of Roczid 1000 Injection on the Kidneys?
Very few cases of side effects of Roczid on kidney have been reported.
What is the effect of Roczid 1000 Injection on the Liver?
Roczid is not harmful for the liver.
What is the effect of Roczid 1000 Injection on the Heart?
Roczid is not harmful for the heart.
If you are suffering from any of the following diseases, you should not take Roczid 1000 Injection unless your doctor advises you to do so -
Is this Roczid 1000 Injection habit forming or addictive?
Roczid 1000 Injection is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Roczid 1000 Injection can make you feel drowsy.
Is it safe?
Roczid 1000 Injection is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
There is no benefit of taking Roczid 1000 Injection for mental disorders.
Interaction between Food and Roczid 1000 Injection
It is safe to take Roczid 1000 Injection with food.
Interaction between Alcohol and Roczid 1000 Injection
It is difficult to say anything about the effect of Roczid 1000 Injection and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; FORTAZ® (ceftazidime)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-312